Oral MS-20 for moderate to severe ulcerative colitis
Part of Digestive system clinical trials.
This trial studies whether an oral treatment called MS-20 can improve ulcerative colitis (UC) in adults with moderate to severe disease. You may be asked to provide stool samples from home and avoid certain foods and medicines before screening and during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 20 to 65 and have confirmed moderate to severe ulcerative colitis
- Your UC diagnosis was made at least 3 months before screening
- You can and will follow study visits and procedures, and communicate with the study team
- You can collect, store (with a fridge), and deliver stool samples from home
- If you can become pregnant, you agree to use reliable birth control or avoid sex during the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called MK-8690 for people with moderate to severe ulcerative colitis (UC) who haven't responded well to other treatments or can't tolerate them. The study aims to see if the drug can help control UC symptoms safely.
This trial tests an experimental drug (ISM5411) for people with active ulcerative colitis. The goal is to see if the drug can reduce inflammation and improve symptoms.
This trial tests a new treatment for people with ulcerative colitis (UC) whose disease is active despite taking only mesalamine or sulfasalazine. It aims to find a therapy that can reduce inflammation and improve symptoms.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
This study tests an investigational drug for people with active mild-to-moderate ulcerative colitis. It aims to see if the drug can improve symptoms without needing advanced treatments like biologics.
This study is testing an investigational medication for moderate to severe ulcerative colitis (UC) that has not responded well to other treatments. The goal is to see if the drug can help reduce inflammation and improve symptoms.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.